{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:12:51Z","timestamp":1783606371244,"version":"3.55.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The cGAS\/STING pathway is a critical signaling hub that orchestrates type I interferon (IFN) responses, autophagy, and programmed cell death in response to double-stranded DNA (dsDNA) or cyclic dinucleotides. While traditionally characterized as a sensor of foreign or mis-localized self dsDNA, recent evidence demonstrates that STING also integrates information about the homeostasis of cellular lipid biosynthesis into the innate inflammatory response. This integration occurs most notably through STING\u2019s sensitivity to\n                    <jats:italic>de novo<\/jats:italic>\n                    cholesterol synthesis. However, given that mammalian cells undergo widespread lipid metabolic reprogramming, characterized by alterations in the synthesis of many lipid species in addition to cholesterol, during processes such as malignant transformation to cancer or during infection by intracellular pathogens, we hypothesized that STING function may be regulated by perturbations in other undescribed lipid pathways. To investigate potential other facets of the STING-lipid interface, we have performed a targeted small molecule screen across multiple lipid metabolic pathways, including the mevalonate, PPAR (fatty acid), and arachidonic acid pathways. Our findings reveal that positively and negatively perturbing enzymes within these diverse lipid paths including lipoxygenases and cyclooxygenases can significantly modulate STING-dependent signal transduction and transcriptional programs, identifying metabolic nodes that link lipid homeostasis with innate immune signaling. These results suggest that existing lipid-lowering and metabolic therapies may have unappreciated immunomodulatory effects on STING applicable in cancer and infectious disease, offering new opportunities for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1784556","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:12:51Z","timestamp":1783602771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted lipid metabolism screening uncovers regulatory effects on the STING immune response in mevalonate, eicosanoid and fatty acid pathways"],"prefix":"10.3389","volume":"17","author":[{"given":"Sofia","family":"Skobelkina","sequence":"first","affiliation":[{"name":"Program in Oncology Marlene and Stewart Greenebaum National Cancer Institute (NCI) Comprehensive Cancer Center","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella L","family":"Brunsting","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology University of Maryland, Baltimore (UMB), School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Program in Oncology Marlene and Stewart Greenebaum National Cancer Institute (NCI) Comprehensive Cancer Center","place":["Baltimore, MD, United States"]},{"name":"Department of Microbiology and Immunology University of Maryland, Baltimore (UMB), School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061845","article-title":"The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis","volume":"204","author":"Roberts","year":"2007","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m112.382986","article-title":"5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential","volume":"287","author":"Prantner","year":"2012","journal-title":"J Biol Chem"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300097","article-title":"Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid","volume":"190","author":"Conlon","year":"2013","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1189801","article-title":"c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response","volume":"328","author":"Woodward","year":"2010","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1228-x","article-title":"A conserved PLPLRT\/SD motif of STING mediates the recruitment and activation of TBK1","volume":"569","author":"Zhao","year":"2019","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00300-24","article-title":"ER-transiting bacterial toxins amplify STING innate immune responses and elicit ER stress","volume":"92","author":"Schlenker","year":"2024","journal-title":"Infect Immun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182192","article-title":"STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death","volume":"216","author":"Wu","year":"2019","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1074\/jbc.m116.763268","article-title":"AMP-activated kinase (AMPK) promotes innate immunity and antiviral defense through modulation of stimulator of interferon genes (STING) signaling","volume":"292","author":"Prantner","year":"2017","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.045","article-title":"Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling","volume":"163","author":"York","year":"2015","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/15578518251407655","article-title":"Sterol regulatory element-binding proteins and metabolic diseases: mechanisms, implications, and therapeutic strategies","author":"Zhang","year":"2025","journal-title":"Metab Syndr Relat Disord"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03762-2","article-title":"Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C","volume":"596","author":"Chu","year":"2021","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2125","article-title":"Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production","volume":"180","author":"Xu","year":"2008","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0243-7","article-title":"Autocrine-paracrine prostaglandin E(2) signaling restricts TLR4 internalization and TRIF signaling","volume":"19","author":"Perkins","year":"2018","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.08.258","article-title":"Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy","volume":"77","author":"Corrales","year":"2016","journal-title":"Cytokine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.12.002","article-title":"Targeting STING to generate therapeutic anti-tumor immunity","volume":"44","author":"Fahey","year":"2025","journal-title":"Cancer Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202104005","article-title":"Lipid droplets and the host-pathogen dynamic: FATal attraction","volume":"220","author":"Bosch","year":"2021","journal-title":"J Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108541","article-title":"High-throughput CRISPR screening identifies genes involved in macrophage viability and inflammatory pathways","volume":"33","author":"Covarrubias","year":"2020","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201644","article-title":"Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice","volume":"190","author":"Pennini","year":"2013","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041250307","article-title":"Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1","volume":"125","author":"Sklar","year":"1985","journal-title":"J Cell Physiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500105","article-title":"Salmonella typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively","volume":"195","author":"Perkins","year":"2015","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00239-10","article-title":"A Toll-like receptor-responsive kinase, protein kinase R, is inactivated in endotoxin tolerance through differential K63\/K48 ubiquitination","volume":"1","author":"Perkins","year":"2010","journal-title":"mBio"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-13-0797","article-title":"Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling","volume":"13","author":"Li","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177890","article-title":"Effectiveness and safety of the SREBP1\/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression","volume":"1003","author":"Arora","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01320.x","article-title":"Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"key":"B40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13340-021-00519-0","article-title":"The forgotten type 2 diabetes mellitus medicine: rosiglitazone","volume":"13","author":"Xu","year":"2022","journal-title":"Diabetol Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2007.0992","article-title":"IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)","volume":"28","author":"Roberts","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/s41467-024-47046-5","article-title":"Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.11.011","article-title":"The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING","volume":"41","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"Radmark","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200599","article-title":"Leukotrienes in innate immunity: still underappreciated after all these years","volume":"210","author":"Serezani","year":"2023","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007244","article-title":"Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice","volume":"14","author":"Brandt","year":"2018","journal-title":"PloS Pathog"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstrom","year":"2018","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117662","article-title":"Eicosanoids and Inflammation: A delicate balance of Pro-Inflammatory and Pro-Resolving mediators","volume":"245","author":"Park","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.007","article-title":"STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses","volume":"34","author":"Vila","year":"2022","journal-title":"Cell Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1588","article-title":"Arachidonic acid metabolism in human prostate cancer","volume":"41","author":"Yang","year":"2012","journal-title":"Int J Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03016-1","article-title":"The role of human 5-lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions","volume":"43","author":"Kahnt","year":"2024","journal-title":"Oncogene"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0695-4","article-title":"Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins","volume":"21","author":"Zhou","year":"2020","journal-title":"Nat Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1177\/17534259251367263","article-title":"Working in negative space: Type I interferon mediated immuno-modulation through transcriptional suppression in disease and homeostasis","volume":"31","author":"Brunsting","year":"2025","journal-title":"Innate Immun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.151","article-title":"Homeostasis-altering molecular processes as mechanisms of inflammasome activation","volume":"17","author":"Liston","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00125.2020","article-title":"Statins activate the NLRP3 inflammasome and impair insulin signaling via p38 and mTOR","volume":"319","author":"Henriksbo","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106272","article-title":"Cellular stress promotes NOD1\/2-dependent inflammation via the endogenous metabolite sphingosine-1-phosphate","volume":"40","author":"Pei","year":"2021","journal-title":"EMBO J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/jci121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101241","article-title":"The STING in non-alcoholic fatty liver diseases: Potential therapeutic targets in inflammation-carcinogenesis pathway","volume":"15","author":"Lv","year":"2022","journal-title":"Pharm (Basel)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708744114","article-title":"DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway","volume":"114","author":"Bai","year":"2017","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1784556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:12:52Z","timestamp":1783602772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1784556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2026.1784556"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1784556","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1784556"}}